Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as Adjunct for Depression in Obese Patients
NCT06707012Phase 4Recruiting
- Sponsor
- Fazaia Ruth Pfau Medical College
- Start
- Oct 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin in major depressive disorder (MDD), sponsored by Fazaia Ruth Pfau Medical College. Started Oct 2025; status: recruiting.
02
Drugs
metformin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06707012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06707012.